Project Details
Description
MRFF 2022 Rapid Applied Research Translation Grant
This national initiative will use implementation science and rapid applied translation techniques in three national paediatric priority areas (asthma, type 1 diabetes [T1D] and antibiotic overuse) to transform levels of evidence-based care provided to Australian children. We are working with all key stakeholders including patients and their families, clinicians, researchers, clinician-researchers, and key state and national bodies (e.g., consumer groups, Medical Colleges, Primary Health Networks and major children’s hospitals), in a program of work with three phases of activities: 1. evidence validation; 2. field-testing; and 3. embedding, scale-up and evaluation. The project will deliver on six of the eight MRFF Measures of Success.
This national initiative will use implementation science and rapid applied translation techniques in three national paediatric priority areas (asthma, type 1 diabetes [T1D] and antibiotic overuse) to transform levels of evidence-based care provided to Australian children. We are working with all key stakeholders including patients and their families, clinicians, researchers, clinician-researchers, and key state and national bodies (e.g., consumer groups, Medical Colleges, Primary Health Networks and major children’s hospitals), in a program of work with three phases of activities: 1. evidence validation; 2. field-testing; and 3. embedding, scale-up and evaluation. The project will deliver on six of the eight MRFF Measures of Success.
| Acronym | N-PARTI |
|---|---|
| Status | Active |
| Effective start/end date | 1/06/24 → 31/05/29 |